William Pridgen serves as Executive at Virios Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, William Pridgen has executed 12 insider transactions totaling $231.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 21, 2023 involved purchasing 15,335 shares valued at $19.9K.
William Pridgen currently holds 52,045 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Pridgen has been a net buyer of VIRI stock. They have purchased $231.9K and sold $0 worth of shares.
William Pridgen's most recent insider trade was on Aug 21, 2023, when they purchased 15,335 shares at $1.30 per share.
Get notified when new Form 4 filings are submitted
| $4.50 |
| Discretionary |
| May 17, 2022 | VIRI | $58.9K | Purchase | 13,450 | $4.38 | Discretionary |
| Mar 29, 2022 | VIRI | $3.0K | Purchase | 600 | $4.94 | Discretionary |
| Mar 23, 2022 | VIRI | $12.0K | Purchase | 2,197 | $5.46 | Discretionary |
| Jan 27, 2022 | VIRI | $25.0K | Purchase | 4,180 | $5.98 | Discretionary |
| Jan 3, 2022 | VIRI | $12.0K | Purchase | 2,215 | $5.43 | Discretionary |
| Dec 21, 2021 | VIRI | $50.0K | Purchase | 8,827 | $5.66 | Discretionary |
| Jul 7, 2021 | VIRI | $6.0K | Purchase | 942 | $6.32 | Discretionary |
| Jan 29, 2021 | VIRI | $26.1K | Purchase | 3,500 | $7.47 | Discretionary |
| Jan 28, 2021 | VIRI | $6.2K | Option Exercise | 801 | $7.80 | Discretionary |
| Dec 17, 2020 | VIRI | $18.0K | Purchase | 1,500 | $11.98 | Discretionary |